Aspirin study for kidney patients halted: did the risks outweigh the benefits?
NCT ID NCT03796156
First seen Mar 20, 2026 · Last updated May 23, 2026 · Updated 8 times
Summary
This study looked at whether taking a daily low-dose aspirin could help prevent a first heart attack or stroke in people with chronic kidney disease (CKD). Aspirin thins the blood to reduce clots but also raises bleeding risk. Over 4,600 adults with CKD from UK clinics were randomly assigned to aspirin or usual care and followed for years. The study was stopped early, and results are being analyzed to see if the benefits of preventing heart attacks and strokes outweigh the bleeding risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nottingham Clinical Trials Unit
Nottingham, NG7 2RD, United Kingdom
Conditions
Explore the condition pages connected to this study.